scholarly journals CROS editorial comment: Cardiac rehabilitation effectiveness in the ‘new era’: Any doubts after an acute coronary event?

2017 ◽  
Vol 24 (8) ◽  
pp. 796-798 ◽  
Author(s):  
Ana Abreu
Keyword(s):  
Editorial Comment ◽  
Cardiac Rehabilitation ◽  
Coronary Event ◽  
Acute Coronary Event ◽  
New Era

scholarly journals Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation

2017 ◽  
Vol Volume 13 ◽  
pp. 55-60 ◽  
Author(s):  
Annett Salzwedel ◽  
Maria Heidler ◽  
Kathrin Haubold ◽  
Martin Schikora ◽  
Rona Reibis ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cardiac Rehabilitation ◽  
Coronary Event ◽  
Acute Coronary Event

Evidence for cardiac rehabilitation in the modern era

2020 ◽  
pp. 1-10
Author(s):  
Constantinos H. Davos ◽  
Bernhard Rauch
Keyword(s):  
Cardiovascular Disease ◽  
Life Expectancy ◽  
Cardiac Rehabilitation ◽  
Meta Analysis ◽  
Coronary Event ◽  
Controlled Trials ◽  
Acute Coronary Event ◽  
Coronary Syndrome ◽  
Modern Era

Management of cardiovascular disease (CVD) has rapidly improved during recent decades and is still changing with the introduction of novel medication and advanced invasive procedures and devices. Notwithstanding these developments, cardiac rehabilitation (CR) is still a cornerstone of secondary prevention. Its effectiveness in improving the physical condition of chronic coronary syndrome (CCS) patients is beyond doubt, but its effectiveness on extending life expectancy is still a matter of debate. This chapter provides insights into the latest evidence (mainly presented in a recent meta-analysis of randomized controlled trials (RCTs) or controlled cohort studies) on the role of CR on morbidity and mortality in patients after an acute coronary event.

Antiepileptic medications and the risk for sudden cardiac death caused by an acute coronary event: a prospective case-control study

2016 ◽  
Vol 48 (1-2) ◽  
pp. 111-117 ◽  
Author(s):  
Eeva Hookana ◽  
Hanna Ansakorpi ◽  
Marja-Leena Kortelainen ◽  
M. Juhani Junttila ◽  
Kari S Kaikkonen ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Case Control Study ◽  
Coronary Event ◽  
Case Control ◽  
Acute Coronary Event ◽  
Antiepileptic Medications ◽  
Control Study ◽  
Prospective Case Control Study

Abstract 3667: Comparison of Risk Profiles between Survivors and Victims of Sudden Cardiac Death of an Acute Coronary Event

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Kari S Kaikkonen ◽  
Marja-Leena Kortelainen ◽  
Heikki V Huikuri
Keyword(s):  
Risk Factors ◽  
Family History ◽  
Sudden Cardiac Death ◽  
Cardiac Hypertrophy ◽  
Odds Ratio ◽  
Cardiac Death ◽  
Coronary Event ◽  
Acute Coronary Event ◽  
Risk Profiles ◽  
History Of

Introduction. There is little information on the specific risk factors leading to sudden cardiac death (SCD) during an acute coronary event, because the risk variables may overlap with those of non-fatal coronary event. This study was designed to compare the risk profiles of SCD victims and survivors of an acute coronary event. Methods and Results. A case-control study included consecutive victims of SCD (n=425, mean age 64±11 years) verified to be due to an acute coronary event at medicolegal autopsy and consecutive patients surviving an acute myocardial infarction (AMI, n=644, mean age 62±10 years). Common cardiovascular risk factors, cardiac hypertrophy, and severity of coronary artery disease (CAD) were assessed in both groups. Family history of SCD (odds ratio 1.5, 95% CI 1.0 to 2.2, p=0.03), male gender (odds ratio 1.8, 95% CI 1.3 to 2.4, p<0.001), current smoking (odds ratio 2.0, 95% CI 1.5 to 2.6, p<0.001), cardiac hypertrophy (odds ratio 3.0, 95% CI 2.3 to 3.9, p<0.001) and 3-vessel CAD (odds ratio 5.4, 95% CI 3.6 to 8.2, p<0.001) were more common among the victims of SCD as compared to survivors of AMI. On the contrary, history of hypercholesterolemia (p<0.001) was less common among the SCD victims. There was a cumulative increase of risk of being a SCD victim vs. AMI survivor when more than one risk factor was present, the odds ratio being 44.3 (95% CI 8.0 to 246.7) in a current male smoker with a family history of SCD and cardiac hypertrophy. When 3-vessel CAD was added to the combined risk score, all subjects (7% of the SCD victims) were in the group of SCD giving a 100% sensitivity and specificity, respectively, in differentiating between the SCD victims and AMI survivors. Conclusions. There are specific features that differentiate the victims of SCD from survivors of an acute coronary event. Clustering of several variables, such as family history of SCD, smoking, cardiac hypertrophy, and 3-vessel CAD indicate a very high risk of SCD.

Sign in / Sign up

Export Citation Format

Share Document